AsOf

Recorded or changed on this day 2026-11-08

301–350 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,377,895,000 United States dollar
Abbott Laboratories quarterly revenue: 5,377,895,000 United States dollar, claim clm_83226985F7C5 · ended · superseded by clm_A00248C0A983 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 594,878,000 United States dollar
Abbott Laboratories quarterly operating income: 594,878,000 United States dollar, claim clm_83E5B8F4B133 · ended · superseded by clm_21EACF91396A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 9,675,000,000 United States dollar
Abbott Laboratories cash and equivalents: 9,675,000,000 United States dollar, claim clm_83F1FF1326CA · ended · superseded by clm_4689BDC0942B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,495,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,495,000,000 United States dollar, claim clm_8501CF976D96 · ended · superseded by clm_57D24A3D8A74 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 20,860,099,000 United States dollar
Abbott Laboratories total equity: 20,860,099,000 United States dollar, claim clm_85CABEE68CB1 · ended · superseded by clm_90D583BDBB9B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 1,400,000,000 United States dollar
Abbott Laboratories net income: 1,400,000,000 United States dollar, claim clm_87CC51296794 · ended · superseded by clm_0E0A2ADD6C11 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 84,181,000,000 United States dollar
Abbott Laboratories total assets: 84,181,000,000 United States dollar, claim clm_87D9C9A99CA7 · ended · superseded by clm_61EE170DDFF9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,698,354,000 United States dollar
Abbott Laboratories quarterly revenue: 7,698,354,000 United States dollar, claim clm_882692ECC7C2 · ended · superseded by clm_BC7C9A4BD8E1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 1,566,820,000 United States dollar
Abbott Laboratories cash and equivalents: 1,566,820,000 United States dollar, claim clm_8831A07FE77A · ended · superseded by clm_CBC630AE4E8D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 12,593,000,000 United States dollar
Abbott Laboratories quarterly revenue: 12,593,000,000 United States dollar, claim clm_88335AA7BB99 · ended · superseded by clm_080974839279 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,770,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,770,000,000 United States dollar, claim clm_886971CE1D04 · ended · superseded by clm_4B304DFC779C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 11,895,000,000 United States dollar
Abbott Laboratories quarterly revenue: 11,895,000,000 United States dollar, claim clm_8A05921A46AB · ended · superseded by clm_3FFAC71D1875 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 40,109,000,000 United States dollar
Abbott Laboratories revenue: 40,109,000,000 United States dollar, claim clm_8BADD4D79F8F · ended · superseded by clm_AC0EC8434FB1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 73,795,000,000 United States dollar
Abbott Laboratories total assets: 73,795,000,000 United States dollar, claim clm_8BE27EF7D3B2 · ended · superseded by clm_4C989819EA90 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 739,000,000 United States dollar
Abbott Laboratories quarterly operating income: 739,000,000 United States dollar, claim clm_8F33F13465E8 · ended · superseded by clm_2F19688C782C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 42,419,204,000 United States dollar
Abbott Laboratories total assets: 42,419,204,000 United States dollar, claim clm_90CA3B235E37 · ended · superseded by clm_D6BE0F2C8B81 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 19,911,709,000 United States dollar
Abbott Laboratories total equity: 19,911,709,000 United States dollar, claim clm_90D583BDBB9B · ended · superseded by clm_F1A1F85FFC33 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 73,269,000,000 United States dollar
Abbott Laboratories total assets: 73,269,000,000 United States dollar, claim clm_915AC243756D · ended · superseded by clm_8BE27EF7D3B2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 7,052,776,000 United States dollar
Abbott Laboratories cash and equivalents: 7,052,776,000 United States dollar, claim clm_9250460C542F · ended · superseded by clm_485B77DCC4E1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 8,425,000,000 United States dollar
Abbott Laboratories operating income: 8,425,000,000 United States dollar, claim clm_92EA1FC35D1F · ended · superseded by clm_504246A9C0D6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,639,753,000 United States dollar
Abbott Laboratories quarterly operating income: 1,639,753,000 United States dollar, claim clm_939A0E0F91C1 · ended · superseded by clm_A7FED0A7C490 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 610,000,000 United States dollar
Abbott Laboratories quarterly operating income: 610,000,000 United States dollar, claim clm_93E168E8343C · ended · superseded by clm_E789F7FC62E7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 580,000,000 United States dollar
Abbott Laboratories quarterly net income: 580,000,000 United States dollar, claim clm_94B13D450A74 · ended · superseded by clm_0603855B1B45 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 2,057,000,000 United States dollar
Abbott Laboratories quarterly operating income: 2,057,000,000 United States dollar, claim clm_94C2592AE159 · ended · superseded by clm_1C0A2724D779 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 21,848,000,000 United States dollar
Abbott Laboratories revenue: 21,848,000,000 United States dollar, claim clm_9516B11C6785 · ended · superseded by clm_0D3539091ADB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 35,802,000,000 United States dollar
Abbott Laboratories total equity: 35,802,000,000 United States dollar, claim clm_962B09128298 · ended · superseded by clm_44B2ADC81A66 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 39,318,000,000 United States dollar
Abbott Laboratories total equity: 39,318,000,000 United States dollar, claim clm_963EBDDEF424 · ended · superseded by clm_CE6B68D9DE0E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,491,719,891 shares
Abbott Laboratories shares outstanding: 1,491,719,891 shares, claim clm_96EE5B28A5A8 · ended · superseded by clm_1B44F2DE8736 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,739,633,759 shares
Abbott Laboratories shares outstanding: 1,739,633,759 shares, claim clm_97F2C8360ADC · ended · superseded by clm_17BF8DBB11AD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,737,682,887 shares
Abbott Laboratories shares outstanding: 1,737,682,887 shares, claim clm_98DC25486509 · ended · superseded by clm_0EA7146A2063 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 654,000,000 United States dollar
Abbott Laboratories quarterly research and development: 654,000,000 United States dollar, claim clm_99642DE8DD5D · ended · superseded by clm_258F725B9941 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,671,420,000 United States dollar
Abbott Laboratories quarterly operating income: 1,671,420,000 United States dollar, claim clm_998AAAD07809 · ended · superseded by clm_939A0E0F91C1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 544,000,000 United States dollar
Abbott Laboratories quarterly net income: 544,000,000 United States dollar, claim clm_99925964117F · ended · superseded by clm_56D74673B58B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,544,028,722 shares
Abbott Laboratories shares outstanding: 1,544,028,722 shares, claim clm_9A07F66DD2FF · ended · superseded by clm_E1CB9197DEA5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 5,693,839,000 United States dollar
Abbott Laboratories operating income: 5,693,839,000 United States dollar, claim clm_9A47D1F92763 · ended · superseded by clm_44311C0CCB22 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 2,447,000,000 United States dollar
Abbott Laboratories quarterly net income: 2,447,000,000 United States dollar, claim clm_9A8A8D8C7B07 · ended · superseded by clm_B88C88ADFFAE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,377,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,377,000,000 United States dollar, claim clm_9ABE667349AF · ended · superseded by clm_4B2593012B5B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 33,562,000,000 United States dollar
Abbott Laboratories total equity: 33,562,000,000 United States dollar, claim clm_9B3045B3D04C · ended · superseded by clm_0E0ED6C2D2F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,648,371,000 United States dollar
Abbott Laboratories cash and equivalents: 3,648,371,000 United States dollar, claim clm_9C0B558E781A · ended · superseded by clm_B1458938F400 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 30,577,000,000 United States dollar
Abbott Laboratories total equity: 30,577,000,000 United States dollar, claim clm_9C4568F5F599 · ended · superseded by clm_3FB8E64381F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,569,333,729 shares
Abbott Laboratories shares outstanding: 1,569,333,729 shares, claim clm_9CD0F79343E3 · ended · superseded by clm_A5733B5B97F8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 30,897,000,000 United States dollar
Abbott Laboratories total equity: 30,897,000,000 United States dollar, claim clm_9D7A48D859AE · ended · superseded by clm_D7620A7ABE34 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 20,722,000,000 United States dollar
Abbott Laboratories total equity: 20,722,000,000 United States dollar, claim clm_9E0E24B3E644 · ended · superseded by clm_08EC8818E782 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,328,000,000 United States dollar
Abbott Laboratories quarterly revenue: 7,328,000,000 United States dollar, claim clm_9EA536FA1B5B · ended · superseded by clm_3B0F0FD9892A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 715,000,000 United States dollar
Abbott Laboratories quarterly research and development: 715,000,000 United States dollar, claim clm_9ED86C910D2E · ended · superseded by clm_F557BBEDA577 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 109,215,000,000 United States dollar
Abbott Laboratories total assets: 109,215,000,000 United States dollar, claim clm_9F11A9C39281 · ended · superseded by clm_408FF4DCACA7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,793,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,793,000,000 United States dollar, claim clm_9F497245599A · ended · superseded by clm_4D5842D1AFBC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,754,319,284 shares
Abbott Laboratories shares outstanding: 1,754,319,284 shares, claim clm_9F7DBFC910F0 · ended · superseded by clm_66C9CF7C9C4F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,480,000,000 United States dollar
Abbott Laboratories cash and equivalents: 4,480,000,000 United States dollar, claim clm_9F84425DB42F · ended · superseded by clm_A8B28B659942 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,469,995,415 shares
Abbott Laboratories shares outstanding: 1,469,995,415 shares, claim clm_9FA1445E4402 · ended · superseded by clm_20D5B4C10A23 · 1 source (1 primary) · conf 0.95

What the statuses mean